1.5 mg tirzepatide Dosage Guide and Chart for Weight Loss Yurpeak® Tirzepatide 5mg KwikPen -

Do NOT Use Weight Loss Injections If You Have: Personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia type 2 (MEN2) History of pancreatitis Severe gastroparesis or other serious GI motility disorder Pregnancy , active breastfeeding, or plans to conceive in the next 2 months History of severe hypersensitivity reaction to any GLP-1 receptor agonist Known or suspected diabetic ketoacidosis Type 1 diabetes (use only with physician supervision, not for weight loss as a primary indication) Active eating disorder involving restriction or purging (relative contraindication, requires specialist input) For people with a history of gallbladder disease , use is possible but requires monitoring

This single variable is the difference between absorption and waste

Overview of How Weight Loss Continues with Sustained Use: Steady progress: Even after the initial weight loss, Tirzepatide continues to support gradual weight loss for many users

Constipation emerges in about 25% of users, resulting from slowed intestinal motility

Whats Not Included